Craft

Advanced
Kancera

Kancera

Stock Price

KR1.7

2024-10-29

Market Capitalization

KR207.2 M

2024-10-29

Kancera Summary

Company Summary

Overview
Kancera is a company that develops drugs against inflammatory diseases and cancer. It regulates the immune system, blocks survival signals in the cancer cell, and addresses repair mechanisms.
Type
Public
Status
Active
Founded
2010
HQ
Solna, SE | view all locations
Website
http://kancera.com/en/
Cybersecurity rating
ESG rating
30-39 out of 100|View all ESG data
Sectors

Table of Contents

Key People

  • Thomas Olin

    Thomas Olin, CEO, Director

    • Anders Gabrielsen

      Anders Gabrielsen, Director

      • Martin Norin

        Martin Norin, COO

        • Petter Brodin

          Petter Brodin, Director

          LocationsView all

          2 locations detected

          • Solna, Stockholms län HQ

            Sweden

            Banvaktsvägen 22

          • Solna, Stockholms län

            Sweden

            Nanna Svartz väg 4

          Kancera Financials

          Summary Financials

          Gross profit (FY, 2025)
          kr14.0K
          Net income (FY, 2025)
          (kr47.2M)
          Cash (FY, 2025)
          kr16.1M
          EBIT (FY, 2025)
          (kr47.6M)

          Competitors and Similar Companies

          Compare competitors

          Footer menu

          Product

          Solutions

          Resources

          Company

          © Craft.co 2026
          Share price data provided by IEX